Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 08, 2022 08:17 ET | Source: InvestorBrandNetwork (IBN)

IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast Featuring Dr. Faz Chowdhury, CEO of Nemaura Medical Inc.

LOS ANGELES, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment...
May 23, 2022 06:30 ET | Source: Nemaura Medical, Inc

Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding

Loughborough, England, May 23, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...
April 25, 2022 08:30 ET | Source: Nemaura Medical, Inc

Nemaura Medical to Present at the Planet MicroCap Showcase 2022

Loughborough, England, April 25, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
February 01, 2021 08:00 ET | Source: Nemaura Medical Inc.

Nemaura Medical Appoints Jay L. Warner as Head of U.S. Commercial Operations

LOUGHBOROUGH, England, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
January 11, 2021 08:00 ET | Source: Nemaura Medical Inc.

Nemaura Medical To Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference

LOUGHBOROUGH, England, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
December 17, 2020 08:00 ET | Source: Nemaura Medical Inc.

Nemaura Medical Launches BEAT®diabetes Program and Its Novel proBEAT™ Non-Invasive, Daily-Wear Adhesive Glucose Monitor

LOUGHBOROUGH, England, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
December 11, 2020 09:00 ET | Source: Nemaura Medical Inc.

Nemaura Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference

LOUGHBOROUGH, England, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
November 17, 2020 08:00 ET | Source: Nemaura Medical Inc.

Nemaura Medical Launches BEAT™diabetes Program Through New Web Presence and Re-Launches Enhanced Corporate Website

LOUGHBOROUGH, England, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
October 22, 2020 08:00 ET | Source: Nemaura Medical Inc.

Nemaura Medical to Present at Virtual Diabetes Technology Meeting 2020

LOUGHBOROUGH, England, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
September 21, 2020 08:00 ET | Source: Nemaura Medical Inc.

Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products

Clinically proven app from Healthimation, LLC, to be paired with Company’s proBEAT™ non-invasive CGM system solution to offer convenient and effective management of pre-diabetes and Type 2 diabetes ...